About Martin Lehr
Form D filings for Praesidia Biotherapeutics from 2021 to 2024 list Martin Lehr as director.
Martin Lehr first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Lehr in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Lehr works with at each company, as listed on that company's latest Form D.
Praesidia Biotherapeutics, Inc. · Form D/A, Jul 17, 2024
SC
Sohang Chatterjee
Chief Executive Officer and director
ST
Shawn Titcomb
Director
PM
Pradip Majumder
Executive officer